Literature DB >> 6864289

Failure of naloxone to affect focal incomplete cerebral ischemia and collateral blood flow in cats.

J L Hubbard, T M Sundt.   

Abstract

Focal incomplete cerebral ischemia was created in 20 adult cats by retro-orbital middle cerebral artery (MCA) occlusion under halothane anesthesia. Arterial blood flow (CBF), bilateral electroencephalographic (EEG) recordings, and systemic arterial blood pressure (SABP) were monitored for the 1st hour of occlusion. Ten animals were treated with 10 mg/kg of naloxone within 10 minutes of MCA clipping, followed by a continuous infusion of naloxone at 2 mg/kg/hr for the duration of the occlusion (8 hours). Ten animals were treated in a similar fashion with physiological saline (control). Blood flow was restored after 8 hours. The brains were examined at the time of death or 7 days after the occlusion period. There was no difference between the two groups regarding cerebral infarction size or distribution, neurological outcome, SABP, PaCO2, or CBF. Minor changes in EEG amplitude observed in the naloxone-treated group appear to represent interaction of the drug with halothane after prolonged administration. The authors conclude that naloxone did not modify the outcome of focal cerebral ischemia in the cat.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6864289     DOI: 10.3171/jns.1983.59.2.0237

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  3 in total

Review 1.  Anesthesia and monitoring for carotid endarterectomy.

Authors:  G J Theisen; B L Grundy
Journal:  Bull N Y Acad Med       Date:  1987-10

2.  Experimental focal cerebral ischaemia in rabbits.

Authors:  K Hegedüs; I Fekete; F Tury; L Molnár
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

3.  A prophylactic bolus of thiopentone does not protect against prolonged focal cerebral ischaemia.

Authors:  A W Gelb; P Floyd; P Lok; S J Peerless; M Farrell
Journal:  Can Anaesth Soc J       Date:  1986-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.